Treatment of Anorexia with Unani Medicine Jawarish-e-Zanjabeel.

Phase 2

Not yet recruiting

• Conditions: Anorexia, Zof-e-Ishteha (Anorexia),

• Registration Number: CTRI/2018/08/015449
• Lead Sponsor: Central Council for Research in Unani Medicine CCRUM New Delhi

Brief Summary

This study is a multicentric open trial in patients with **Zof-e-Ishteha (Anorexia)** After screening, Patients will be enrolled if they satisfy inclusion and exclusion criteria.  The patients will be assessed clinically at every weekly.  This includes subjective assessment of general well being and physical examination . The total duration of treatment will be 2 weeks. Laboratory parameters for safety assessment will be conducted at baseline and on completion of the protocol therapy

Composition ofJawarish –e-Zanjabeel(NFUM-I, Page 106)

| | | |

| --- | --- | --- |

|**S. No.**

**Ingredients**

**Quantity**

|

Zanjabeel

100g

|

Samagh e Arabi

50 g

|

Dana Heel Khurd

50 g

|

Belgiri

50g

|

Saleekha

25g

|

Zarambad

10g

|

Nishasta e Gandum

200g

|

Qand e safaid

450g

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2018-04-12
• Study Start: 2018-08-24

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 240

Inclusion Criteria

• Patients of any sex in the age group 19-65 years 2.
• Patients having Zu‘f al-IshtihÄ’ (Anorexia) with SNAQ score ≤ 14.

Exclusion Criteria

• Patients having Anorexia nervosa 2.
• Patients having any systemic disease, chronic debilitating disease, T.B., Diabetes Mellitus etc.
• Known cases of Hepatic, Renal or Cardiac Ailments 4.
• History of hypersensitivity to study drug or any of its ingredients.
• History of addiction (Alcohol, Drugs) 6.
• Pregnant and lactating women.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Improvement in the sign and symptoms of NisyÄn (Amnesia)	Two Weeks

Secondary Outcome Measures

Name	Time	Method
Hematological and biochemical assessments for safety	two weeks

Trial Locations

Locations (2)

Clinical Research Unit (CRU) Burhanpur; 🇮🇳 Nimar, MADHYA PRADESH, India

Regional Research Institute of Unani Medicine; 🇮🇳 Bhadrak, ORISSA, India

Clinical Research Unit (CRU) Burhanpur

🇮🇳Nimar, MADHYA PRADESH, India

Dr S Noor Mohammad

Principal investigator

08109462242

mahajankk@rediffmail.com